69 related articles for article (PubMed ID: 18028765)
1. The effect of celecoxib on tissue factor expression in pancreatic cancer cells.
Wang HY; Yang YM; Zhuang Y; Chen HN; Wan YL; Huang YT
Chin Med J (Engl); 2007 Oct; 120(20):1753-6. PubMed ID: 18028765
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib potently inhibits TNFalpha-induced nuclear translocation and activation of NF-kappaB.
Funakoshi-Tago M; Shimizu T; Tago K; Nakamura M; Itoh H; Sonoda Y; Kasahara T
Biochem Pharmacol; 2008 Sep; 76(5):662-71. PubMed ID: 18644347
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation.
Steffel J; Hermann M; Greutert H; Gay S; Lüscher TF; Ruschitzka F; Tanner FC
Circulation; 2005 Apr; 111(13):1685-9. PubMed ID: 15795326
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells.
Steffel J; Akhmedov A; Fähndrich C; Ruschitzka F; Lüscher TF; Tanner FC
Biochem Biophys Res Commun; 2006 Oct; 349(2):597-603. PubMed ID: 16949034
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor kappa B activation is a potential target for preventing pancreatic carcinoma by aspirin.
Sclabas GM; Uwagawa T; Schmidt C; Hess KR; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2005 Jun; 103(12):2485-90. PubMed ID: 15861417
[TBL] [Abstract][Full Text] [Related]
6. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells.
Kim SH; Hwang CI; Park WY; Lee JH; Song YS
Carcinogenesis; 2006 Oct; 27(10):1961-9. PubMed ID: 16597647
[TBL] [Abstract][Full Text] [Related]
7. Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation.
Hirata Y; Masuda Y; Kakutani H; Higuchi T; Takada K; Ito A; Nakagawa Y; Ishii H
Biochem Pharmacol; 2008 Apr; 75(7):1504-14. PubMed ID: 18261712
[TBL] [Abstract][Full Text] [Related]
8. Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
Yip-Schneider MT; Wu H; Njoku V; Ralstin M; Holcomb B; Crooks PA; Neelakantan S; Sweeney CJ; Schmidt CM
Pancreas; 2008 Oct; 37(3):e45-53. PubMed ID: 18815538
[TBL] [Abstract][Full Text] [Related]
9. IkappaBalpha kinase inhibitor IKI-1 conferred tumor necrosis factor alpha sensitivity to pancreatic cancer cells and a xenograft tumor model.
Zhang Y; Gavriil M; Lucas J; Mandiyan S; Follettie M; Diesl V; Sum FW; Powell D; Haney S; Abraham R; Arndt K
Cancer Res; 2008 Nov; 68(22):9519-24. PubMed ID: 19010928
[TBL] [Abstract][Full Text] [Related]
10. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib up-regulates the expression of the zeta chain of T cell receptor complex in tumor-infiltrating lymphocytes in human cervical cancer.
Ferrandina G; Ranelletti FO; Legge F; Salutari V; Martinelli E; Fattorossi A; Lorusso D; Zannoni G; Vellone V; Paglia A; Scambia G
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2055-60. PubMed ID: 16609015
[TBL] [Abstract][Full Text] [Related]
12. Altered gene expression profiles define pathways in colorectal cancer cell lines affected by celecoxib.
Fatima N; Yi M; Ajaz S; Stephens RM; Stauffer S; Greenwald P; Munroe DJ; Ali IU
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3051-61. PubMed ID: 18957522
[TBL] [Abstract][Full Text] [Related]
13. [Effects of a selective cyclooxygenase 2 inhibitor celecoxib on the proliferation and apoptosis of human prostate cancer cell line PC-3].
Xu S; Zhou WQ; Zhang ZY; Ge JP; Gao JP
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):489-93. PubMed ID: 18649743
[TBL] [Abstract][Full Text] [Related]
14. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
[TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
16. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis.
Olivares C; Bilotas M; Buquet R; Borghi M; Sueldo C; Tesone M; Meresman G
Hum Reprod; 2008 Dec; 23(12):2701-8. PubMed ID: 18716040
[TBL] [Abstract][Full Text] [Related]
17. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.
Hobbs JE; Zakarija A; Cundiff DL; Doll JA; Hymen E; Cornwell M; Crawford SE; Liu N; Signaevsky M; Soff GA
Thromb Res; 2007; 120 Suppl 2():S13-21. PubMed ID: 18023707
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor effects of specific cyclooxygenase inhibitors combined with chemotherapeutic agents on gastric cancer cells in vitro].
Zhu FS; Chen XM; Wang YJ; Zhang X; Feng JX
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):186-8. PubMed ID: 17649633
[TBL] [Abstract][Full Text] [Related]
20. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2.
Maussang D; Langemeijer E; Fitzsimons CP; Stigter-van Walsum M; Dijkman R; Borg MK; Slinger E; Schreiber A; Michel D; Tensen CP; van Dongen GA; Leurs R; Smit MJ
Cancer Res; 2009 Apr; 69(7):2861-9. PubMed ID: 19318580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
